Originally published on U.S. Bank company blog

For two decades, Rolando Pozos worked as an investment banker specializing in advising companies on mergers and acquisitions. Then he made an acquisition of his own.

It started with a meeting, arranged by a mutual friend, with the owner of Amapola Deli & Market, a chain of three Los Angeles-area stores specializing in Latin American food products, who was looking to develop a succession plan.

“He reached out to me for some friendly advice, knowing I was a Latino investment banker who spoke Spanish,” Pozos said.

Pozos was a loyal customer of Amapola, which opened its first location in 1961, and as he learned more about the business, he became increasingly intrigued and eventually decided he could be the ideal successor.

“I realized it would be a great place for me to start all over again as an entrepreneur and follow a new career path,” Pozos said. “It was something that happened very organically. I wasn’t looking to be in this industry.”

As the new owner of Amapola and a U.S. Bank client, Pozos, who was born and raised in Monterrey, Mexico, brought an extensive background in business, having earned an MBA at the University of Southern California before going into banking. He also brought a love of Mexican food, including the homemade tamales, stew and soups his grandmother prepared when he was young.

“We grew up getting together as a family and celebrating with food,” he said.

Pozos has continued that celebration with his wife, Megan, and two young children.

“We are learning how to make tamales as a family,” Pozos said. “It helps our kids stay away from their iPads on Sunday afternoons, and through Amapola Market, we are teaching our kids how to experience and pass on traditions.”

Amapola Markets, a U.S. Bank client, have meat markets, bakeries and service delis, make fresh tortillas and specialize in corn products made without genetically modified ingredients. The markets, according to Pozos, are the region’s largest producer of fresh masa, a ground corn-based dough used for making tortillas, tamales, tostadas and other Latin American dishes.

“During the holiday season, in particular, we sell millions of pounds of masa,” Pozos said. “It’s so important for us to continue to provide the very best of our Latin food heritage to our customers.”

When Pozos acquired the company, he resolved to continue making the company’s products in the traditional way of cooking, grinding and working with corn, but also saw opportunities to expand the offerings.

Under his leadership, the company has expanded its product line to include natural juices, salsas, desserts, dry chilies and other Latin food essentials. He has increased the number of Amapola employees from 250 to 300 and said he has been boosting food production by about 10% a year.

The biggest strategic move, Pozos said, has been further increasing production volumes to sell products through other stores, with Amapola-branded products now being sold by nearly 150 retailers across Los Angeles.

“We can reach more customers and communities at a faster pace if we do it through other retailers,” he said. “We prefer to do what we do best, which is to produce our food, and then we’ll have other people make it available in places across Los Angeles, California and the West Coast.”

In light of these changes, Pozos was named a Greater Los Angeles Entrepreneur of the Year 2023 by Ernst & Young.

Pozos said his goal is to make Amapola a national brand enjoyed regularly by people of all ethnic backgrounds. He plans to open production facilities beyond California, and he’s working to strengthen his supply chain.

U.S. Bank provides Amapola Market credit, treasury management and financial advisory services.

“U.S. Bank is a very important partner for our company,” Pozos said. “They help us manage our day-to-day cash flow needs. They also understand our growth plans and are consulting with us on how we can inject capital into the business to grow our manufacturing footprint in other states.”

Cummins

Watch the latest video from Cummins Water Works featuring Cummins Inc. colleagues working in the wetlands of the Maipo Basin in Chile. Through our partnership with The Nature Conservancy, Cummins Chile employees are volunteering to help restore the High Andean wetlands, which play a crucial role in filtering water that comes from the glaciers and mitigating flooding and erosion.

The Maipo Basin provides 80% of freshwater to Santiago, and water for agriculture, mining and other industries in the region. Cummins employees are helping monitor key water indicators in the wetlands and participating in restoration and conservation activities. So far, their work has generated more than 38 million gallons of net water benefits per year.

About Cummins Inc.

Cummins Inc., a global power solutions leader, is comprised of five business segments – Components, Engine, Distribution, Power Systems and Accelera by Cummins – supported by our global manufacturing and extensive service and support network, skilled workforce and vast technological expertise. Cummins is committed to its Destination Zero strategy, which is grounded in the company’s commitment to sustainability and helping its customers successfully navigate the energy transition with its broad portfolio of products. The products range from advanced diesel, natural gas, electric and hybrid powertrains and powertrain-related components including filtration, aftertreatment, turbochargers, fuel systems, valvetrain technologies, controls systems, air handling systems, automated transmissions, axles, drivelines, brakes, suspension systems, electric power generation systems, batteries, electrified power systems, hydrogen production technologies and fuel cell products. Headquartered in Columbus, Indiana (U.S.), since its founding in 1919, Cummins employs approximately 75,500 people committed to powering a more prosperous world through three global corporate responsibility priorities critical to healthy communities: education, environment and equality of opportunity. Cummins serves its customers online, through a network of company-owned and independent distributor locations, and through thousands of dealer locations worldwide and earned about $735 million on sales of $34.1 billion in 2023. See how Cummins is powering a world that’s always on by accessing news releases and more information at https://www.cummins.com/.

© 2024 Cummins Inc. All rights reserved.

Cummins

Watch the latest video from Cummins Water Works featuring Cummins Inc. colleagues working in the wetlands of the Maipo Basin in Chile. Through our partnership with The Nature Conservancy, Cummins Chile employees are volunteering to help restore the High Andean wetlands, which play a crucial role in filtering water that comes from the glaciers and mitigating flooding and erosion.

The Maipo Basin provides 80% of freshwater to Santiago, and water for agriculture, mining and other industries in the region. Cummins employees are helping monitor key water indicators in the wetlands and participating in restoration and conservation activities. So far, their work has generated more than 38 million gallons of net water benefits per year.

About Cummins Inc.

Cummins Inc., a global power solutions leader, is comprised of five business segments – Components, Engine, Distribution, Power Systems and Accelera by Cummins – supported by our global manufacturing and extensive service and support network, skilled workforce and vast technological expertise. Cummins is committed to its Destination Zero strategy, which is grounded in the company’s commitment to sustainability and helping its customers successfully navigate the energy transition with its broad portfolio of products. The products range from advanced diesel, natural gas, electric and hybrid powertrains and powertrain-related components including filtration, aftertreatment, turbochargers, fuel systems, valvetrain technologies, controls systems, air handling systems, automated transmissions, axles, drivelines, brakes, suspension systems, electric power generation systems, batteries, electrified power systems, hydrogen production technologies and fuel cell products. Headquartered in Columbus, Indiana (U.S.), since its founding in 1919, Cummins employs approximately 75,500 people committed to powering a more prosperous world through three global corporate responsibility priorities critical to healthy communities: education, environment and equality of opportunity. Cummins serves its customers online, through a network of company-owned and independent distributor locations, and through thousands of dealer locations worldwide and earned about $735 million on sales of $34.1 billion in 2023. See how Cummins is powering a world that’s always on by accessing news releases and more information at https://www.cummins.com/.

© 2024 Cummins Inc. All rights reserved.

Originally published on Illumina News Center

A recent literature review, published in the Nature journal Genomic Medicine, showed that short-read genomic sequencing (GS) reduces the time it takes to diagnose and treat pediatric patients who may have a rare genetic condition. This evidence supports efforts to make GS the first-line standard of care, particularly for patients in neonatal intensive care units (NICU) and other critical care settings.

“Historically we have used a stair-step approach to diagnose these conditions, starting with the least comprehensive tests,” says Ryan Taft, PhD, vice president of Scientific Research at Illumina and an author of the study. “If the first efforts fail to produce a diagnosis, more sophisticated tests are then used, and eventually genomic sequencing is used as a last resort. But this approach wastes time and resources and can be emotionally devastating for families who are left without answers. The evidence shows that, in many cases, sequencing is the most effective diagnostic approach—whenever possible, we just use genome sequencing as our first port of call.”

The study was conducted by the Medical Genome Initiative (MGI), a consortium of clinical genomic sequencing laboratories working to expand access to high-quality GS. As reported in their latest manuscript, there is significant evidence that genomic sequencing excels as a diagnostic test for rare genetic diseases, but clinical adoption has been unexpectedly slow.

To fully assess the evidence for GS in rare genetic disease populations, the MGI conducted a focused literature review and meta-analysis. A total of 71 papers met their criteria, published between January 2014 and August 2022, which included over 13,000 patients. The studies were evaluated based on their analysis strategies, including the types of variants analyzed, interpretation guidelines, health care settings, secondary findings, turnaround times, cohort phenotypes, diagnostic yields, and clinical utility.

Overall, the study found an average diagnostic yield of 45% for first-tier genomic sequencing, compared to 33% in groups that had received earlier genetic testing and 33% in patients who did not receive a diagnosis from exome sequencing. Clinical utility was reported by one-third of the studies. Changes in management described included outcome efficacy across diagnostic thinking, treatment, patient outcomes, and social impacts, and the authors found a broad range of reported rates of changes in management (20%–100%) since the methods used to assess clinical utility varied from one study to the next.

“The evidence shows that, in many scenarios, genomic sequencing should be the first-line genetic test,” Taft says. “Pediatric patients in intensive care units who have unexplained conditions should be first in line. Also, if a targeted panel doesn’t include all the suspected genes that might be causing the child’s condition, comprehensive genomic sequencing can fill those gaps.”

In addition to offering high diagnostic yields, genomic sequencing is fast. Rapid approaches, pioneered over the past few years, can produce results in a matter of days, a capability that has been particularly beneficial for critically ill babies in NICUs. Less comprehensive alternatives to GS can waste precious time and delay much-needed diagnoses.

While this review highlights the many benefits of genomic sequencing in critical care settings, more work remains to be done. The authors found little published research on first-line GS in outpatient and other less urgent scenarios. Additional studies will be needed; however, for many patients, the evidence clearly supports the clinical efficacy of genomic sequencing.

“There is still resistance to pursue genomic sequencing because of the perception that the price is too high,” Taft says, “but this fails to account for recent dramatic reductions in GS costs and its impact on the downstream continuum of care. Getting precision answers sooner, particularly for patients with rare genetic disorders, is almost always the most cost-effective approach.”

Register here for the Medical Genome Initiative’s webinar on April 25, 2024. Sponsored by Illumina, Dr. Kristen Wigby will speak on topics related to whole-genome sequencing for rare disease.

Originally published on Illumina News Center

A recent literature review, published in the Nature journal Genomic Medicine, showed that short-read genomic sequencing (GS) reduces the time it takes to diagnose and treat pediatric patients who may have a rare genetic condition. This evidence supports efforts to make GS the first-line standard of care, particularly for patients in neonatal intensive care units (NICU) and other critical care settings.

“Historically we have used a stair-step approach to diagnose these conditions, starting with the least comprehensive tests,” says Ryan Taft, PhD, vice president of Scientific Research at Illumina and an author of the study. “If the first efforts fail to produce a diagnosis, more sophisticated tests are then used, and eventually genomic sequencing is used as a last resort. But this approach wastes time and resources and can be emotionally devastating for families who are left without answers. The evidence shows that, in many cases, sequencing is the most effective diagnostic approach—whenever possible, we just use genome sequencing as our first port of call.”

The study was conducted by the Medical Genome Initiative (MGI), a consortium of clinical genomic sequencing laboratories working to expand access to high-quality GS. As reported in their latest manuscript, there is significant evidence that genomic sequencing excels as a diagnostic test for rare genetic diseases, but clinical adoption has been unexpectedly slow.

To fully assess the evidence for GS in rare genetic disease populations, the MGI conducted a focused literature review and meta-analysis. A total of 71 papers met their criteria, published between January 2014 and August 2022, which included over 13,000 patients. The studies were evaluated based on their analysis strategies, including the types of variants analyzed, interpretation guidelines, health care settings, secondary findings, turnaround times, cohort phenotypes, diagnostic yields, and clinical utility.

Overall, the study found an average diagnostic yield of 45% for first-tier genomic sequencing, compared to 33% in groups that had received earlier genetic testing and 33% in patients who did not receive a diagnosis from exome sequencing. Clinical utility was reported by one-third of the studies. Changes in management described included outcome efficacy across diagnostic thinking, treatment, patient outcomes, and social impacts, and the authors found a broad range of reported rates of changes in management (20%–100%) since the methods used to assess clinical utility varied from one study to the next.

“The evidence shows that, in many scenarios, genomic sequencing should be the first-line genetic test,” Taft says. “Pediatric patients in intensive care units who have unexplained conditions should be first in line. Also, if a targeted panel doesn’t include all the suspected genes that might be causing the child’s condition, comprehensive genomic sequencing can fill those gaps.”

In addition to offering high diagnostic yields, genomic sequencing is fast. Rapid approaches, pioneered over the past few years, can produce results in a matter of days, a capability that has been particularly beneficial for critically ill babies in NICUs. Less comprehensive alternatives to GS can waste precious time and delay much-needed diagnoses.

While this review highlights the many benefits of genomic sequencing in critical care settings, more work remains to be done. The authors found little published research on first-line GS in outpatient and other less urgent scenarios. Additional studies will be needed; however, for many patients, the evidence clearly supports the clinical efficacy of genomic sequencing.

“There is still resistance to pursue genomic sequencing because of the perception that the price is too high,” Taft says, “but this fails to account for recent dramatic reductions in GS costs and its impact on the downstream continuum of care. Getting precision answers sooner, particularly for patients with rare genetic disorders, is almost always the most cost-effective approach.”

Register here for the Medical Genome Initiative’s webinar on April 25, 2024. Sponsored by Illumina, Dr. Kristen Wigby will speak on topics related to whole-genome sequencing for rare disease.

Curiosity Cube mobile science lab plans to reach 45,000 students in 14 countriesLessons educate students on sustainability topics, such as renewable energy and recycled materialsReinforces company commitment to increase equity in STEM education; addresses growing need for students to pursue STEM careers

BURLINGTON, Mass., April 17, 2024 /3BL/ – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, officially kicked off its global 2024 Curiosity Cube tour today in Darmstadt, Germany. The solar-powered shipping containers turned mobile science labs are once again visiting communities across North America and Europe. MilliporeSigma’s goal is to engage 45,000 students to increase access to hands-on STEM education for students through interactive science experiences.

“Recent data shows students between 8 and 13 years old are interested in science and math, with most calling these subjects fun and exciting. Yet, this interest and enthusiasm is not translating into students pursuing STEM careers, as they find it hard to see themselves as scientists,” said Tim Jaeger, Chief Strategy and Transformation Officer for the Life Science business sector of Merck KGaA, Darmstadt, Germany. “Our Curiosity Cube encourages children’s scientific curiosity with hands-on experiments showcasing real-world applications. Students also meet our employees, who can be role models for the incredible range of STEM careers that are possible.”

For the 2024 tour, the Curiosity Cube is sporting a new look, displaying photos of young scientists who are children of MilliporeSigma employees. These employees work in a range of roles at the company from project management and human resources to manufacturing and supply chain. This helps illustrate the numerous career options available in STEM.

The hands-on experiments are led by local MilliporeSigma employees at each stop who guide lessons focused on sustainability using the lifecycle of a t-shirt as an example. Students will:

Learn about synthetic and natural fibers, examining them through microscopes and categorizing them based on their level of sustainability.Design and test a windmill that produces enough renewable energy to power a model t-shirt factory.Use a threading machine to learn how old clothing can be sorted, shredded into fibers, and re-spun into thread for new garments.

In North America, the Curiosity Cube already embarked on its sixth tour, with 137 events across the U.S. and Canada, including Austin, Boston, Cleveland, Houston, Kansas City, Milwaukee, Seattle, St. Louis, Toronto, and more.

Embarking on its third tour of Europe, the Curiosity Cube will host 150 events. Stops include communities across Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Liechtenstein, the Netherlands, Spain, Switzerland and the U.K. MilliporeSigma also operates stationary Curiosity Cubes at its sites in St. Louis, USA and Darmstadt, Germany. This underscores the company’s commitment to the communities where many of its employees live and work.

To learn more about the Curiosity Cube mobile science lab and view the 2024 tour schedule, visit TheCuriosityCube.com and follow the Curiosity Cube on Instagram @curiositycube_milliporesigma.

About the Life Science business of Merck KGaA, Darmstadt, Germany

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 28,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.

Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.

Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.

All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.

Curiosity Cube mobile science lab plans to reach 45,000 students in 14 countriesLessons educate students on sustainability topics, such as renewable energy and recycled materialsReinforces company commitment to increase equity in STEM education; addresses growing need for students to pursue STEM careers

BURLINGTON, Mass., April 17, 2024 /3BL/ – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, officially kicked off its global 2024 Curiosity Cube tour today in Darmstadt, Germany. The solar-powered shipping containers turned mobile science labs are once again visiting communities across North America and Europe. MilliporeSigma’s goal is to engage 45,000 students to increase access to hands-on STEM education for students through interactive science experiences.

“Recent data shows students between 8 and 13 years old are interested in science and math, with most calling these subjects fun and exciting. Yet, this interest and enthusiasm is not translating into students pursuing STEM careers, as they find it hard to see themselves as scientists,” said Tim Jaeger, Chief Strategy and Transformation Officer for the Life Science business sector of Merck KGaA, Darmstadt, Germany. “Our Curiosity Cube encourages children’s scientific curiosity with hands-on experiments showcasing real-world applications. Students also meet our employees, who can be role models for the incredible range of STEM careers that are possible.”

For the 2024 tour, the Curiosity Cube is sporting a new look, displaying photos of young scientists who are children of MilliporeSigma employees. These employees work in a range of roles at the company from project management and human resources to manufacturing and supply chain. This helps illustrate the numerous career options available in STEM.

The hands-on experiments are led by local MilliporeSigma employees at each stop who guide lessons focused on sustainability using the lifecycle of a t-shirt as an example. Students will:

Learn about synthetic and natural fibers, examining them through microscopes and categorizing them based on their level of sustainability.Design and test a windmill that produces enough renewable energy to power a model t-shirt factory.Use a threading machine to learn how old clothing can be sorted, shredded into fibers, and re-spun into thread for new garments.

In North America, the Curiosity Cube already embarked on its sixth tour, with 137 events across the U.S. and Canada, including Austin, Boston, Cleveland, Houston, Kansas City, Milwaukee, Seattle, St. Louis, Toronto, and more.

Embarking on its third tour of Europe, the Curiosity Cube will host 150 events. Stops include communities across Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Liechtenstein, the Netherlands, Spain, Switzerland and the U.K. MilliporeSigma also operates stationary Curiosity Cubes at its sites in St. Louis, USA and Darmstadt, Germany. This underscores the company’s commitment to the communities where many of its employees live and work.

To learn more about the Curiosity Cube mobile science lab and view the 2024 tour schedule, visit TheCuriosityCube.com and follow the Curiosity Cube on Instagram @curiositycube_milliporesigma.

About the Life Science business of Merck KGaA, Darmstadt, Germany

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 28,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.

Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.

Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.

All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.

What Does it Mean to Farm Soy Sustainably?

U.S. soybean farmers, pioneers of sustainable farming, grow many of the soy products you know and love, from the soy milk in your latte to the tofu in your veggie bowl. But they’re not just growing delicious soy foods. They’re also the guardians of our land, ensuring it thrives and produces food for future generations, for years to come.

Today, U.S. soybean farmers are dedicated to sustainable farming practices, working hard to do more with less. They have increased total soybean production by 130% to bring us the soy foods we love, even as they reduce GHG emissions and energy and fuel use.

What drives them? First is the desire to do right by you and our earth, producing nutritious protein with fewer resources. Second is the knowledge that we will need to grow 61% more food by 2050 to feed our rising population, which is expected to increase by 2 billion people over the next 30 years!

This goal spurs U.S. soybean farmers to continue innovating, so they can continue growing the nutrition we need while working in harmony with the earth. Now, let’s meet a few of the U.S. soybean farmers who put the soy foods on your plate and hear what growing sustainable soy means to them.

Meet Soy Farmers: Meagan Kaiser & April Hemmes

“I truly care about how I raise my crops and how I market them, and also, how I sustainably raise them to leave this land in better condition for future generations of my family.”
– April Hemmes, Iowa Soybean Farmer

In Iowa and Missouri respectively, Meagan Kaiser, both a soil scientist and farmer, and April Hemmes, a fourth-generation farmer, consider their farms to be much more than just fields—they’re thriving, bustling with biodiversity.

In recent years, the U.S. has sought to revitalize its commitment to biodiversity, with new laws and programs shifting towards a greener, more sustainable future. U.S. soybean farmers, like Kaiser and Hemmes, are in step with this movement, making choices to use diverse crops, conserve soil through tillage techniques and preserve natural habitats. Through these efforts, they cultivate a harmonious relationship with nature, ensuring the health and resilience of their farms and the ecosystem around them.

Watch how Meagan Kaiser and April Hemmes work with Mother Nature to strengthen the soil and restore our earth.

Meet Soy Farmers: Laurie Isley & Matt Gast

“I am proud to be one of the many U.S. soybean farmers employing sustainable farming practices. We are putting more effort and investment than ever before into reducing greenhouse gas emissions and water usage.”
– Laurie Isley, Michigan Soybean Farmer

For Laurie Isley, a fifth-generation farmer in Michigan, and Matt Gast, a soybean farmer hailing from North Dakota, sustainability isn’t just a buzzword; it’s a way of life.

Using cutting-edge tools like smart irrigation, drones, and bioengineering, U.S. soybean farmers like Laurie and Matt are at the forefront of sustainable farming practices. Their dedication to reducing greenhouse gas emissions, conserving water and maximizing productivity reflects the core values of the U.S. soybean farming community, where sustainability is a top priority.

Learn about the ways Laurie and Matt employ sustainable practices on their farms.

Next time you’re picking up soy products, why not go for U.S.-grown?

Committed to sustainable practices on their soy farms, making our planet a healthier place to live. And since 98% of U.S. farms are family owned, you’re supporting the next generation of sustainable farming.

Meet more of the U.S. soybean farmers behind the food on your plate, and explore how they put agricultural technology, like bioengineering, drones and smart irrigation, to work to improve the health of our planet. And if you want to explore further, take a look at the United Soybean Board’s 2023 Sustainability Overview Report!

What Does it Mean to Farm Soy Sustainably?

U.S. soybean farmers, pioneers of sustainable farming, grow many of the soy products you know and love, from the soy milk in your latte to the tofu in your veggie bowl. But they’re not just growing delicious soy foods. They’re also the guardians of our land, ensuring it thrives and produces food for future generations, for years to come.

Today, U.S. soybean farmers are dedicated to sustainable farming practices, working hard to do more with less. They have increased total soybean production by 130% to bring us the soy foods we love, even as they reduce GHG emissions and energy and fuel use.

What drives them? First is the desire to do right by you and our earth, producing nutritious protein with fewer resources. Second is the knowledge that we will need to grow 61% more food by 2050 to feed our rising population, which is expected to increase by 2 billion people over the next 30 years!

This goal spurs U.S. soybean farmers to continue innovating, so they can continue growing the nutrition we need while working in harmony with the earth. Now, let’s meet a few of the U.S. soybean farmers who put the soy foods on your plate and hear what growing sustainable soy means to them.

Meet Soy Farmers: Meagan Kaiser & April Hemmes

“I truly care about how I raise my crops and how I market them, and also, how I sustainably raise them to leave this land in better condition for future generations of my family.”
– April Hemmes, Iowa Soybean Farmer

In Iowa and Missouri respectively, Meagan Kaiser, both a soil scientist and farmer, and April Hemmes, a fourth-generation farmer, consider their farms to be much more than just fields—they’re thriving, bustling with biodiversity.

In recent years, the U.S. has sought to revitalize its commitment to biodiversity, with new laws and programs shifting towards a greener, more sustainable future. U.S. soybean farmers, like Kaiser and Hemmes, are in step with this movement, making choices to use diverse crops, conserve soil through tillage techniques and preserve natural habitats. Through these efforts, they cultivate a harmonious relationship with nature, ensuring the health and resilience of their farms and the ecosystem around them.

Watch how Meagan Kaiser and April Hemmes work with Mother Nature to strengthen the soil and restore our earth.

Meet Soy Farmers: Laurie Isley & Matt Gast

“I am proud to be one of the many U.S. soybean farmers employing sustainable farming practices. We are putting more effort and investment than ever before into reducing greenhouse gas emissions and water usage.”
– Laurie Isley, Michigan Soybean Farmer

For Laurie Isley, a fifth-generation farmer in Michigan, and Matt Gast, a soybean farmer hailing from North Dakota, sustainability isn’t just a buzzword; it’s a way of life.

Using cutting-edge tools like smart irrigation, drones, and bioengineering, U.S. soybean farmers like Laurie and Matt are at the forefront of sustainable farming practices. Their dedication to reducing greenhouse gas emissions, conserving water and maximizing productivity reflects the core values of the U.S. soybean farming community, where sustainability is a top priority.

Learn about the ways Laurie and Matt employ sustainable practices on their farms.

Next time you’re picking up soy products, why not go for U.S.-grown?

Committed to sustainable practices on their soy farms, making our planet a healthier place to live. And since 98% of U.S. farms are family owned, you’re supporting the next generation of sustainable farming.

Meet more of the U.S. soybean farmers behind the food on your plate, and explore how they put agricultural technology, like bioengineering, drones and smart irrigation, to work to improve the health of our planet. And if you want to explore further, take a look at the United Soybean Board’s 2023 Sustainability Overview Report!

Saskia Kort-Chick| Director of Social Research and Engagement—Responsibility

Markus Schneider| Senior Economist—EEMEA

Understanding the social risks posed by climate transition requires discipline, nuance and a systematic approach.

The concept of a “just transition” has gained ground among responsible investors concerned about the economic consequences of the social risks that countries face in moving from fossil fuels to alternative energy sources. These risks are particularly high in emerging markets (EMs). How can investors systematically measure them?

Put simply, a just transition entails transitioning from fossil fuels in a way that is mindful of the economic impacts and not disruptive of the social fabric of economies.

The consequences of a mismanaged transition may be significant in coal- or oil-exporting countries, especially those with relatively undiversified economies. As demand for these commodities declines, such countries may face more significant transition risks. Governments may face fiscal and debt challenges that pressure their sovereign credit ratings. Worse, economic privation and civil unrest may lead to political instability and even regime change.

In developing a systematic approach to assessing these risks, it helps to focus on the sector at the center of most transition strategies: energy production, particularly coal (the most carbon-intensive fossil fuel). This has the added advantage that coal transitions already under way—such as those of Germany, Poland, the UK and the US—provide policy lessons and examples of pitfalls to avoid. These can be a useful lens through which to analyze how EMs are managing their just transitions.

Policy Lessons: Learning from Experience

Policy lessons show, for example, that a holistic and integrated government planning process is necessary, focusing on workers’ welfare, economic diversification, and social and environmental preservation. Without the help and commitment of national and local governments, a just transition is unlikely to succeed.

Planning is essential, but the reality is that macroeconomic preconditions such as existing levels of industrialization and access to infrastructure matter hugely in government efforts to diversify coal regions. Also, prevailing labor market protection and social security networks are crucial in protecting workers during their transition into alternative employment. In that context, the locations of coal mines are important too, as diversification in very remote areas (where many EM mines are situated) is difficult.

Relative Transition Risks and Specific Vulnerabilities

Informed by past policy lessons, we created a Just Transition Index (JTI) that scores countries across a range of key indicators. The scores are intended to capture a country’s overall level of macroeconomic development and the locations of its mines, the make-up of its labor and energy markets, government policy commitment to a just transition, and the ability to finance it.

Some indicators are relatively easy to measure quantitatively (such as a country’s level of development, exposure of its labor market to coal, and government budget capacity), while others (for example, coal mine locations and government commitment to reform) are harder to quantify.

For this reason, we opted for a qualitative index to score each country from –2 to 2, where the lowest numbers represent the most risk (Display). The JTI provides a guide not only to countries’ overall relative risk (contained in their score averages) but also specific vulnerabilities (individual factor scores).

But the value to investors of such an approach lies not only in its systematic aspects. The underlying qualitative research is critical for understanding the nuances of transition risk.

Preconditions Are a Key Variable

As noted earlier, EMs are particularly exposed. For example, EM labor rights and opportunities tend to be less extensive than those in developed countries. In India, Indonesia and China, coal production is located far from urban centers, limiting the scope for easing coal-dependent populations into alternative employment without the cost and disruption of relocation.

Poland illustrates this well. The country began its transition away from coal more than 30 years ago. Though the transition hasn’t been seamless, it has worked well in one major respect: many of Poland’s coal mining areas are co-located with key industries, such as automobile manufacturers and information and communications technology service providers.

The situation is different in Indonesia. Coal production there is heavily concentrated in Kalimantan and South Sumatra and accounts for 35% of East Kalimantan’s GDP. These areas are remote from the islands of Java and Bali, which together account for 60% of both Indonesia’s population and its GDP. But this challenge may be mitigated by plans to relocate Indonesia’s capital city—currently Jakarta, on the northwest coast of Java—to East Kalimantan.

A Practical and Potentially Rewarding Approach

Other policy lessons reflected by these examples are that stakeholders’ expectations should be managed (as Poland shows, transition can take decades) and strategies should be holistic, not piecemeal. (In Poland’s case, funding and other assistance from the European Union helped to coordinate mining-sector restructuring with the creation of new jobs.)

Just transition is a huge, complex and long-term challenge, in emerging markets and elsewhere. A systematic approach backed by solid fundamental qualitative research offers investors a practical and potentially rewarding way of engaging with it.

The authors would like to thank Roxanne Low, ESG Analyst with AB’s Responsible Investing team, and Kristian Tonev, Fixed Income Associate, for their research contributions.

The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams. Views are subject to change over time.

Learn more about AB’s approach to responsibility here.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.